Loading…

COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC

Purpose. This study is aimed at investigating the expression, underlying biological function, and clinical significance of coatomer protein complex subunit beta 2 (COPB2) in hepatocellular carcinoma (HCC). Methods. HCC-related data were extracted from The Cancer Genome Atlas (TCGA) database, Interna...

Full description

Saved in:
Bibliographic Details
Published in:BioMed research international 2021, Vol.2021, p.6648078-14
Main Authors: Zhang, Jiayao, Wang, Xiaoyu, Li, Guangbing, He, Jingyi, Lu, Ziwen, Yang, Yang, Jiang, Yong, Jiang, Liyong, Li, Feiyu, Liu, Jun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose. This study is aimed at investigating the expression, underlying biological function, and clinical significance of coatomer protein complex subunit beta 2 (COPB2) in hepatocellular carcinoma (HCC). Methods. HCC-related data were extracted from The Cancer Genome Atlas (TCGA) database, International Cancer Genome Consortium (ICGC) database, and Gene Expression Omnibus (GEO) database. A logistic regression module was applied to analyze the relationship between the expression of COPB2 and clinicopathologic characteristics. The Cox proportional hazard regression model and Kaplan–Meier method were used for survival analysis. Gene set enrichment analysis (GSEA) was used to annotate the underlying biological functions. Loss-of-function experiments were conducted to determine the underlying mechanisms. Results. COPB2 was overexpressed in HCC, and high expression of COPB2 was significantly correlated with higher alpha fetoprotein (AFP) (odds ratio OR=1.616, >20 vs. ≤20, p
ISSN:2314-6133
2314-6141
DOI:10.1155/2021/6648078